Arrowhead Research Corporation (ARWR)
NASDAQ: Health Care
$4.12
-0.05 | -1.20%
-0.05 | -1.20%
Today's Range:
4.05 -
4.37
ARWR Avg. Daily Volume:
24,500
05/25/12 - 3:53 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.12 |
| 52 Week High | 11.90 |
| 52 Week Low | 3.12 |
| Avg. Daily Vol. (Mil) | 0.02 |
| Beta (3 year) | 2.43 |
| Share Related Items | |
| Mkt Cap (Mil) | 46.20 |
| Shares Out (Mil) | 11.21 |
| Float (Mil) | 10.43 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.30 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.17 |
| Total Debt / Equity | 0.19 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 836.81 |
| Price/Book | 3.78 |
| Price/Cash Flow | -3.80 |
| Per Share Data | |
| Earnings | -1.45 |
| Sales | 0.00 |
| Book Value | 1.09 |
| Cash Flow | -1.09 |
| Business Summary | |
|---|---|
| Arrowhead Research Corporation is a development stage nanotechnology holding company that forms, acquires, and operates subsidiaries commercializing innovative nanotechnologies. | |
| General Information | |
| 201 South Lake Avenue
Suite 703 Pasedena, CA 91101 |
|
| www.arrowheadresearch.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 57 | |
| CEO: Dr. Christopher Anzalone | |
| Short Interest | |
| Current Month (Mil) | 0.28 |
| Previous Month (Mil) | 0.28 |
| Short Interest Ratio (Days) | 12.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -65.90 |
| Return on Investments | -92.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet